These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 21124888

  • 1. Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study.
    French MD, Churcher TS, Gambhir M, Fenwick A, Webster JP, Kabatereine NB, Basáñez MG.
    PLoS Negl Trop Dis; 2010 Nov 23; 4(11):e897. PubMed ID: 21124888
    [Abstract] [Full Text] [Related]

  • 2. Estimation of changes in the force of infection for intestinal and urogenital schistosomiasis in countries with schistosomiasis control initiative-assisted programmes.
    French MD, Churcher TS, Webster JP, Fleming FM, Fenwick A, Kabatereine NB, Sacko M, Garba A, Toure S, Nyandindi U, Mwansa J, Blair L, Bosqué-Oliva E, Basáñez MG.
    Parasit Vectors; 2015 Oct 24; 8():558. PubMed ID: 26499981
    [Abstract] [Full Text] [Related]

  • 3. Increasing teacher motivation and supervision is an important but not sufficient strategy for improving praziquantel uptake in Schistosoma mansoni control programs: serial cross sectional surveys in Uganda.
    Muhumuza S, Katahoire A, Nuwaha F, Olsen A.
    BMC Infect Dis; 2013 Dec 13; 13():590. PubMed ID: 24330594
    [Abstract] [Full Text] [Related]

  • 4. Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission.
    Barbosa LM, Reis EA, Dos Santos CR, Costa JM, Carmo TM, Aminu PT, Pitanga TN, Ponce-Terashima R, Blank WA, Silva LK, Reis MG, Blanton RE.
    Int J Parasitol; 2016 May 13; 46(5-6):343-50. PubMed ID: 26953255
    [Abstract] [Full Text] [Related]

  • 5. Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali.
    Deol A, Webster JP, Walker M, Basáñez MG, Hollingsworth TD, Fleming FM, Montresor A, French MD.
    Parasit Vectors; 2016 Oct 12; 9(1):543. PubMed ID: 27729063
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.
    Faust CL, Crotti M, Moses A, Oguttu D, Wamboko A, Adriko M, Adekanle EK, Kabatereine N, Tukahebwa EM, Norton AJ, Gower CM, Webster JP, Lamberton PHL.
    Parasit Vectors; 2019 Dec 27; 12(1):607. PubMed ID: 31881923
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya.
    Onkanga IO, Mwinzi PN, Muchiri G, Andiego K, Omedo M, Karanja DM, Wiegand RE, Secor WE, Montgomery SP.
    Int J Parasitol; 2016 Jun 27; 46(7):439-45. PubMed ID: 26940547
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Praziquantel Treatment of Schistosoma mansoni Infected Mice Renders Them Less Susceptible to Reinfection.
    Nono JK, Mpotje T, Mosala P, Aziz NA, Musaigwa F, Hlaka L, Spangenberg T, Brombacher F.
    Front Immunol; 2021 Jun 27; 12():748387. PubMed ID: 34956183
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme.
    Gower CM, Gehre F, Marques SR, Lamberton PHL, Lwambo NJ, Webster JP.
    Parasit Vectors; 2017 Dec 02; 10(1):593. PubMed ID: 29197426
    [Abstract] [Full Text] [Related]

  • 19. Mass drug administration with praziquantel reduces the prevalence of Schistosoma mansoni and improves liver morbidity in untreated preschool children.
    Cleland CR, Tukahebwa EM, Fenwick A, Blair L.
    Trans R Soc Trop Med Hyg; 2014 Sep 02; 108(9):575-81. PubMed ID: 25059523
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.